| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1004716420 |
| P356 | DOI | 10.1038/SJ.BMT.1703771 |
| P698 | PubMed publication ID | 12476282 |
| P5875 | ResearchGate publication ID | 10996449 |
| P50 | author | Norbert Graf | Q39739734 |
| P2093 | author name string | Schulz A | |
| Zintl F | |||
| Klingebiel T | |||
| Koscielniak E | |||
| Niemeyer C | |||
| Laws HJ | |||
| Hero B | |||
| Kremens B | |||
| Finckenstein FG | |||
| Wawer A | |||
| Selle B | |||
| Hasan C | |||
| Gruhn B | |||
| P2860 | cites work | Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study | Q69350980 |
| Expression of the neurotrophin-receptor TrkB predicts outcome in nephroblastomas: results of a pilot-study | Q74442043 | ||
| Complete Recovery of Renal Fuction in a Wilms’ Tumor Patient After Acute Renal Failure Caused by Autologous Bone Marrow Transplantation (ABMT) | Q74618625 | ||
| High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study | Q77435847 | ||
| Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study | Q32034383 | ||
| Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group | Q33181845 | ||
| Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group | Q33182388 | ||
| Carboplatin dosage: prospective evaluation of a simple formula based on renal function | Q33429552 | ||
| Etoposide and carboplatin: a highly effective combination in relapsed or refractory Wilms' tumor--a phase II study by the French Society of Pediatric Oncology | Q33492548 | ||
| Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group | Q33494058 | ||
| The role of preoperative chemotherapy in the management of Wilms' tumor. The SIOP studies. International Society of Pediatric Oncology | Q34031404 | ||
| The treatment of Wilms' tumour: results of the United Kingdom Children's cancer study group (UKCCSG) second Wilms' tumour study | Q36621777 | ||
| Ifosfamide is an active drug in Wilms' tumor: a phase II study conducted by the French Society of Pediatric Oncology | Q40786897 | ||
| Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group | Q40949538 | ||
| The management of relapsed Wilms tumor. | Q40964169 | ||
| Response rates in relapsed wilms' tumor. A need for new effective agents | Q44357176 | ||
| Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor | Q44474541 | ||
| Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A Pediatric Oncology Group Phase II study | Q46382300 | ||
| Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study | Q52534486 | ||
| Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study | Q52879866 | ||
| Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial | Q53433545 | ||
| Autologous bone marrow transplantation for pediatric Wilms' tumor: the experience of the European Bone Marrow Transplantation Solid Tumor Registry | Q54218094 | ||
| High dose consolidation with autologous stem cell rescue (ASCR) for nephroblastoma initially treated according to the SIOP 9/GPOH trial and study* | Q57339801 | ||
| P2507 | corrigendum / erratum | Erratum: High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma | Q57339701 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 893-898 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma | |
| P478 | volume | 30 |
| Q40518066 | A pilot trial of tandem autologous peripheral blood progenitor cell transplantation following high-dose thiotepa and carboplatin in children with poor-risk central nervous system tumors |
| Q28083988 | Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration |
| Q36284506 | Autologous hematopoietic stem cell transplantation for pediatric solid tumors |
| Q53650236 | Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors |
| Q37189302 | Banking on cord blood stem cells |
| Q55024194 | Chemotherapy protocols and incidence of oral mucositis. An integrative review. |
| Q47209459 | Clinical pharmacology of etoposide in children undergoing autologous stem cell transplantation for various solid tumours |
| Q37111805 | Current and emerging chemotherapy treatment strategies for Wilms tumor in North America |
| Q37818231 | Double High-Dose Chemotherapy and Stem Cell Transplantation in Adult Wilms’ Tumor |
| Q92266466 | Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer |
| Q24197545 | Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer |
| Q24235525 | Hepatic late adverse effects after antineoplastic treatment for childhood cancer |
| Q93096849 | Hepatic late adverse effects after antineoplastic treatment for childhood cancer |
| Q90168408 | High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation |
| Q37313322 | Improved survival in patients with recurrent Wilms tumor: the experience of the Seoul National University Children's Hospital |
| Q37287143 | Management of Wilms tumor: current standard of care |
| Q35560198 | Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: clinical outcomes in a context of specialized oral care using low-level laser therapy |
| Q47966224 | Outcomes following autologous hematopoietic stem cell transplant for patients with relapsed Wilms' tumor: a CIBMTR retrospective analysis |
| Q48564189 | Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol |
| Q57339611 | Renal Tumors |
| Q37188465 | SCT for Wilms' tumour. |
| Q37642795 | Treatment of relapsed Wilms tumors: lessons learned. |
| Q57339637 | Value and difficulties of a common European strategy for recurrent Wilms’ tumor |
| Q36381288 | Wilms' tumor: past, present and (possibly) future. |
| Q36938098 | Wilms' tumour in adults: a case report and review of the literature. |
| Q57339701 | Erratum: High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma | main subject | P921 |
Search more.